Request for Covid-19 Impact Assessment of this Report
The United States RNA Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global RNA Medicine market, reaching US$ million by the year 2028. As for the Europe RNA Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main RNA Medicine players cover Pfizer, Roche, Sanofi-Aventis, and Abbott Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Medicine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Medicine Market Size 2017-2028
2.1.2 RNA Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 RNA Medicine Segment by Type
2.2.1 siRNA
2.2.2 ASO
2.2.3 miRNA
2.2.4 Nucleic Acid Aptamers
2.3 RNA Medicine Market Size by Type
2.3.1 RNA Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global RNA Medicine Market Size Market Share by Type (2017-2022)
2.4 RNA Medicine Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Tuberculosis
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 RNA Medicine Market Size by Application
2.5.1 RNA Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global RNA Medicine Market Size Market Share by Application (2017-2022)
3 RNA Medicine Market Size by Player
3.1 RNA Medicine Market Size Market Share by Players
3.1.1 Global RNA Medicine Revenue by Players (2020-2022)
3.1.2 Global RNA Medicine Revenue Market Share by Players (2020-2022)
3.2 Global RNA Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA Medicine by Regions
4.1 RNA Medicine Market Size by Regions (2017-2022)
4.2 Americas RNA Medicine Market Size Growth (2017-2022)
4.3 APAC RNA Medicine Market Size Growth (2017-2022)
4.4 Europe RNA Medicine Market Size Growth (2017-2022)
4.5 Middle East & Africa RNA Medicine Market Size Growth (2017-2022)
5 Americas
5.1 Americas RNA Medicine Market Size by Country (2017-2022)
5.2 Americas RNA Medicine Market Size by Type (2017-2022)
5.3 Americas RNA Medicine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Medicine Market Size by Region (2017-2022)
6.2 APAC RNA Medicine Market Size by Type (2017-2022)
6.3 APAC RNA Medicine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA Medicine by Country (2017-2022)
7.2 Europe RNA Medicine Market Size by Type (2017-2022)
7.3 Europe RNA Medicine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Medicine by Region (2017-2022)
8.2 Middle East & Africa RNA Medicine Market Size by Type (2017-2022)
8.3 Middle East & Africa RNA Medicine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA Medicine Market Forecast
10.1 Global RNA Medicine Forecast by Regions (2023-2028)
10.1.1 Global RNA Medicine Forecast by Regions (2023-2028)
10.1.2 Americas RNA Medicine Forecast
10.1.3 APAC RNA Medicine Forecast
10.1.4 Europe RNA Medicine Forecast
10.1.5 Middle East & Africa RNA Medicine Forecast
10.2 Americas RNA Medicine Forecast by Country (2023-2028)
10.2.1 United States RNA Medicine Market Forecast
10.2.2 Canada RNA Medicine Market Forecast
10.2.3 Mexico RNA Medicine Market Forecast
10.2.4 Brazil RNA Medicine Market Forecast
10.3 APAC RNA Medicine Forecast by Region (2023-2028)
10.3.1 China RNA Medicine Market Forecast
10.3.2 Japan RNA Medicine Market Forecast
10.3.3 Korea RNA Medicine Market Forecast
10.3.4 Southeast Asia RNA Medicine Market Forecast
10.3.5 India RNA Medicine Market Forecast
10.3.6 Australia RNA Medicine Market Forecast
10.4 Europe RNA Medicine Forecast by Country (2023-2028)
10.4.1 Germany RNA Medicine Market Forecast
10.4.2 France RNA Medicine Market Forecast
10.4.3 UK RNA Medicine Market Forecast
10.4.4 Italy RNA Medicine Market Forecast
10.4.5 Russia RNA Medicine Market Forecast
10.5 Middle East & Africa RNA Medicine Forecast by Region (2023-2028)
10.5.1 Egypt RNA Medicine Market Forecast
10.5.2 South Africa RNA Medicine Market Forecast
10.5.3 Israel RNA Medicine Market Forecast
10.5.4 Turkey RNA Medicine Market Forecast
10.5.5 GCC Countries RNA Medicine Market Forecast
10.6 Global RNA Medicine Forecast by Type (2023-2028)
10.7 Global RNA Medicine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer RNA Medicine Product Offered
11.1.3 Pfizer RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche RNA Medicine Product Offered
11.2.3 Roche RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Information
11.3.2 Sanofi-Aventis RNA Medicine Product Offered
11.3.3 Sanofi-Aventis RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sanofi-Aventis Main Business Overview
11.3.5 Sanofi-Aventis Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories RNA Medicine Product Offered
11.4.3 Abbott Laboratories RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Information
11.5.2 Arrowhead Pharmaceuticals RNA Medicine Product Offered
11.5.3 Arrowhead Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Arrowhead Pharmaceuticals Main Business Overview
11.5.5 Arrowhead Pharmaceuticals Latest Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Information
11.6.2 Benitec Biopharma RNA Medicine Product Offered
11.6.3 Benitec Biopharma RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Benitec Biopharma Main Business Overview
11.6.5 Benitec Biopharma Latest Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Information
11.7.2 Calimmune Inc RNA Medicine Product Offered
11.7.3 Calimmune Inc RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Calimmune Inc Main Business Overview
11.7.5 Calimmune Inc Latest Developments
11.8 Dicerna
11.8.1 Dicerna Company Information
11.8.2 Dicerna RNA Medicine Product Offered
11.8.3 Dicerna RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Dicerna Main Business Overview
11.8.5 Dicerna Latest Developments
11.9 Gradalis
11.9.1 Gradalis Company Information
11.9.2 Gradalis RNA Medicine Product Offered
11.9.3 Gradalis RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Gradalis Main Business Overview
11.9.5 Gradalis Latest Developments
11.10 Quark
11.10.1 Quark Company Information
11.10.2 Quark RNA Medicine Product Offered
11.10.3 Quark RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Quark Main Business Overview
11.10.5 Quark Latest Developments
11.11 RXi
11.11.1 RXi Company Information
11.11.2 RXi RNA Medicine Product Offered
11.11.3 RXi RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 RXi Main Business Overview
11.11.5 RXi Latest Developments
11.12 Senesco
11.12.1 Senesco Company Information
11.12.2 Senesco RNA Medicine Product Offered
11.12.3 Senesco RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Senesco Main Business Overview
11.12.5 Senesco Latest Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Information
11.13.2 Silence Therapeutics RNA Medicine Product Offered
11.13.3 Silence Therapeutics RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Silence Therapeutics Main Business Overview
11.13.5 Silence Therapeutics Latest Developments
11.14 Silenseed
11.14.1 Silenseed Company Information
11.14.2 Silenseed RNA Medicine Product Offered
11.14.3 Silenseed RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Silenseed Main Business Overview
11.14.5 Silenseed Latest Developments
11.15 Tekmira
11.15.1 Tekmira Company Information
11.15.2 Tekmira RNA Medicine Product Offered
11.15.3 Tekmira RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Tekmira Main Business Overview
11.15.5 Tekmira Latest Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Information
11.16.2 Alnylam Pharmaceuticals RNA Medicine Product Offered
11.16.3 Alnylam Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Alnylam Pharmaceuticals Main Business Overview
11.16.5 Alnylam Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. RNA Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of siRNA
Table 3. Major Players of ASO
Table 4. Major Players of miRNA
Table 5. Major Players of Nucleic Acid Aptamers
Table 6. RNA Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global RNA Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global RNA Medicine Market Size Market Share by Type (2017-2022)
Table 9. RNA Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global RNA Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global RNA Medicine Market Size Market Share by Application (2017-2022)
Table 12. Global RNA Medicine Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global RNA Medicine Revenue Market Share by Player (2020-2022)
Table 14. RNA Medicine Key Players Head office and Products Offered
Table 15. RNA Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global RNA Medicine Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global RNA Medicine Market Size Market Share by Regions (2017-2022)
Table 20. Americas RNA Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas RNA Medicine Market Size Market Share by Country (2017-2022)
Table 22. Americas RNA Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas RNA Medicine Market Size Market Share by Type (2017-2022)
Table 24. Americas RNA Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas RNA Medicine Market Size Market Share by Application (2017-2022)
Table 26. APAC RNA Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC RNA Medicine Market Size Market Share by Region (2017-2022)
Table 28. APAC RNA Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC RNA Medicine Market Size Market Share by Type (2017-2022)
Table 30. APAC RNA Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC RNA Medicine Market Size Market Share by Application (2017-2022)
Table 32. Europe RNA Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe RNA Medicine Market Size Market Share by Country (2017-2022)
Table 34. Europe RNA Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe RNA Medicine Market Size Market Share by Type (2017-2022)
Table 36. Europe RNA Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe RNA Medicine Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa RNA Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa RNA Medicine Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa RNA Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa RNA Medicine Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa RNA Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa RNA Medicine Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of RNA Medicine
Table 45. Key Market Challenges & Risks of RNA Medicine
Table 46. Key Industry Trends of RNA Medicine
Table 47. Global RNA Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global RNA Medicine Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global RNA Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global RNA Medicine Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global RNA Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global RNA Medicine Market Size Market Share Forecast by Application (2023-2028)
Table 53. Pfizer Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 54. Pfizer RNA Medicine Product Offered
Table 55. Pfizer RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Roche Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 59. Roche RNA Medicine Product Offered
Table 60. Roche Main Business
Table 61. Roche RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Roche Latest Developments
Table 63. Sanofi-Aventis Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 64. Sanofi-Aventis RNA Medicine Product Offered
Table 65. Sanofi-Aventis Main Business
Table 66. Sanofi-Aventis RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Sanofi-Aventis Latest Developments
Table 68. Abbott Laboratories Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 69. Abbott Laboratories RNA Medicine Product Offered
Table 70. Abbott Laboratories Main Business
Table 71. Abbott Laboratories RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Abbott Laboratories Latest Developments
Table 73. Arrowhead Pharmaceuticals Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 74. Arrowhead Pharmaceuticals RNA Medicine Product Offered
Table 75. Arrowhead Pharmaceuticals Main Business
Table 76. Arrowhead Pharmaceuticals RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Arrowhead Pharmaceuticals Latest Developments
Table 78. Benitec Biopharma Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 79. Benitec Biopharma RNA Medicine Product Offered
Table 80. Benitec Biopharma Main Business
Table 81. Benitec Biopharma RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Benitec Biopharma Latest Developments
Table 83. Calimmune Inc Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 84. Calimmune Inc RNA Medicine Product Offered
Table 85. Calimmune Inc Main Business
Table 86. Calimmune Inc RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Calimmune Inc Latest Developments
Table 88. Dicerna Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 89. Dicerna RNA Medicine Product Offered
Table 90. Dicerna Main Business
Table 91. Dicerna RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Dicerna Latest Developments
Table 93. Gradalis Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 94. Gradalis RNA Medicine Product Offered
Table 95. Gradalis Main Business
Table 96. Gradalis RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Gradalis Latest Developments
Table 98. Quark Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 99. Quark RNA Medicine Product Offered
Table 100. Quark Main Business
Table 101. Quark RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Quark Latest Developments
Table 103. RXi Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 104. RXi RNA Medicine Product Offered
Table 105. RXi RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. RXi Main Business
Table 107. RXi Latest Developments
Table 108. Senesco Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 109. Senesco RNA Medicine Product Offered
Table 110. Senesco Main Business
Table 111. Senesco RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Senesco Latest Developments
Table 113. Silence Therapeutics Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 114. Silence Therapeutics RNA Medicine Product Offered
Table 115. Silence Therapeutics Main Business
Table 116. Silence Therapeutics RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Silence Therapeutics Latest Developments
Table 118. Silenseed Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 119. Silenseed RNA Medicine Product Offered
Table 120. Silenseed Main Business
Table 121. Silenseed RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Silenseed Latest Developments
Table 123. Tekmira Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 124. Tekmira RNA Medicine Product Offered
Table 125. Tekmira Main Business
Table 126. Tekmira RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Tekmira Latest Developments
Table 128. Alnylam Pharmaceuticals Details, Company Type, RNA Medicine Area Served and Its Competitors
Table 129. Alnylam Pharmaceuticals RNA Medicine Product Offered
Table 130. Alnylam Pharmaceuticals Main Business
Table 131. Alnylam Pharmaceuticals RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. Alnylam Pharmaceuticals Latest Developments
List of Figures
Figure 1. RNA Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA Medicine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global RNA Medicine Market Size Market Share by Type in 2021
Figure 7. RNA Medicine in Cancer
Figure 8. Global RNA Medicine Market: Cancer (2017-2022) & ($ Millions)
Figure 9. RNA Medicine in Diabetes
Figure 10. Global RNA Medicine Market: Diabetes (2017-2022) & ($ Millions)
Figure 11. RNA Medicine in Tuberculosis
Figure 12. Global RNA Medicine Market: Tuberculosis (2017-2022) & ($ Millions)
Figure 13. RNA Medicine in Cardiovascular Diseases
Figure 14. Global RNA Medicine Market: Cardiovascular Diseases (2017-2022) & ($ Millions)
Figure 15. RNA Medicine in Others
Figure 16. Global RNA Medicine Market: Others (2017-2022) & ($ Millions)
Figure 17. Global RNA Medicine Market Size Market Share by Application in 2021
Figure 18. Global RNA Medicine Revenue Market Share by Player in 2021
Figure 19. Global RNA Medicine Market Size Market Share by Regions (2017-2022)
Figure 20. Americas RNA Medicine Market Size 2017-2022 ($ Millions)
Figure 21. APAC RNA Medicine Market Size 2017-2022 ($ Millions)
Figure 22. Europe RNA Medicine Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa RNA Medicine Market Size 2017-2022 ($ Millions)
Figure 24. Americas RNA Medicine Value Market Share by Country in 2021
Figure 25. Americas RNA Medicine Consumption Market Share by Type in 2021
Figure 26. Americas RNA Medicine Market Size Market Share by Application in 2021
Figure 27. United States RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC RNA Medicine Market Size Market Share by Region in 2021
Figure 32. APAC RNA Medicine Market Size Market Share by Application in 2021
Figure 33. China RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 37. India RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe RNA Medicine Market Size Market Share by Country in 2021
Figure 40. Europe RNA Medicine Market Size Market Share by Type in 2021
Figure 41. Europe RNA Medicine Market Size Market Share by Application in 2021
Figure 42. Germany RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 43. France RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa RNA Medicine Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa RNA Medicine Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa RNA Medicine Market Size Market Share by Application in 2021
Figure 50. Egypt RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country RNA Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 56. APAC RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 57. Europe RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 59. United States RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 60. Canada RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 61. Mexico RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 62. Brazil RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 63. China RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 64. Japan RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 65. Korea RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 67. India RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 68. Australia RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 69. Germany RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 70. France RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 71. UK RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 72. Italy RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 73. Russia RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 74. Spain RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 75. Egypt RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 76. South Africa RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 77. Israel RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 78. Turkey RNA Medicine Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries RNA Medicine Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...